Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, PR China.
Int J Pharm. 2013 Aug 16;452(1-2):241-8. doi: 10.1016/j.ijpharm.2013.05.011. Epub 2013 May 13.
Gastro-floating tablets of cephalexin were developed to prolong the residence time in major absorption sites. Gastro-floating tablets were prepared and optimized using hydroxypropyl methylcellulose (HPMC K100M) as matrix and sodium bicarbonate as a gas-forming agent. The properties of the tablets in terms of floating lag time, floating time and in vitro release were evaluated. Furthermore, in vivo pharmacokinetic study in fed and fasted beagle dogs was performed. The gastro-floating tablets had short floating lag time and exhibited a satisfactory sustained-release profile in vitro. Compared with conventional capsules, the gastro-floating tablets presented a sustained-release behavior with a relative bioavailability of 99.4%, while the reference sustained-release tablets gave a relative bioavailability of only 39.3%. Meanwhile, the food had significant effect on the pharmacokinetics of sustained-release tablets. It was concluded that the gastro-floating tablets had a sustained-release effect in vitro and in vivo, as well as desired pharmacokinetic properties in both fed and fasted conditions.
头孢氨苄胃漂浮片的研制旨在延长其在主要吸收部位的驻留时间。以羟丙甲纤维素(HPMC K100M)为基质,碳酸氢钠为气体发生剂,制备并优化了胃漂浮片。考察了片剂的漂浮滞后时间、漂浮时间和体外释放性能。此外,还进行了在禁食和进食状态下比格犬体内的药代动力学研究。胃漂浮片具有较短的漂浮滞后时间,并在体外呈现出令人满意的持续释放特征。与普通胶囊相比,胃漂浮片呈现出持续释放行为,相对生物利用度为 99.4%,而参比的缓释片的相对生物利用度仅为 39.3%。同时,食物对缓释片的药代动力学有显著影响。结论是,胃漂浮片在体外和体内均具有缓释作用,并且在禁食和进食条件下均具有理想的药代动力学特性。